Oramed Pharmaceuticals Inc.

ORMPNASDAQHealthcare● Active

$3.64

$-0.07(-1.89%)

Market Cap$148970935

P/E Ratio—

52W High$5.01

52W Low$1.98

Avg Volume155K

Open$3.68

Beta1.24

Overview

Oramed Pharmaceuticals Inc.（ORMP）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

ormp · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 8 位华尔街分析师

Buy

8 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 8 · 买入占比: 75.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $3.64

Oramed Pharmaceuticals Inc.（ORMP）的分析师共识为 Buy，基于过去 3 个月内 8 位华尔街分析师的评级。ORMP 的 12 个月平均目标价为 $0.00，相对当前价 $3.64 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-10	$3.46	↓ 5.00%	$3.43	$3.48

1-day model range: $3.43–$3.48. Peak: $3.48 (-5.00%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$2	$3	$3	-29.3%
2028	$2	$2	$2	-39.6%
2029	$2	$2	$2	-44.1%
2030	$2	$2	$2	-46.1%
2031	$2	—	$2	-47.1%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

21%0%79%

3Buy

0Neutral

11Sell

RSI (14)27.9Oversold

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ORMP · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$3.68SELL

MA 10$3.83SELL

MA 20$4.13SELL

MA 50$3.90SELL

MA 100$3.66SELL

MA 200$3.11BUY

Current $ORMP · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$3.72SELL

EMA 10$3.83SELL

EMA 20$3.94SELL

EMA 50$3.88SELL

EMA 100$3.65SELL

EMA 200$3.28BUY

Current $ORMP · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2023-05-17	Canaccord Genuity	Maintains	Hold→Hold
2023-01-17	HC Wainwright & Co.	Downgrade ↓	Buy→Neutral
2023-01-12	Canaccord Genuity	Downgrade ↓	Buy→Hold
2022-05-16	Aegis Capital	Maintains	Buy→Buy
2022-02-18	Cantor Fitzgerald	Maintains	Overweight→Overweight
2021-11-30	HC Wainwright & Co.	Maintains	Buy→Buy
2021-11-29	HC Wainwright & Co.	Maintains	Buy→Buy
2021-11-02	Aegis Capital	Maintains	Buy→Buy
2021-07-29	Canaccord Genuity	Maintains	Buy→Buy
2021-06-08	Aegis Capital	Maintains	Buy→Buy

Canaccord Genuity2023-05-17

Maintains

Hold→Hold

HC Wainwright & Co.2023-01-17

Downgrade ↓

Buy→Neutral

Canaccord Genuity2023-01-12

Downgrade ↓

Buy→Hold

Aegis Capital2022-05-16

Maintains

Buy→Buy

Cantor Fitzgerald2022-02-18

Maintains

Overweight→Overweight

HC Wainwright & Co.2021-11-30

Maintains

Buy→Buy

HC Wainwright & Co.2021-11-29

Maintains

Buy→Buy

Aegis Capital2021-11-02

Maintains

Buy→Buy

Canaccord Genuity2021-07-29

Maintains

Buy→Buy

Aegis Capital2021-06-08

Maintains

Buy→Buy

Wall Street analysts have recently issued updated ratings on Oramed Pharmaceuticals Inc. (ORMP) stock. Of the recent 19 rating actions, 0 were upgrades and 2 were downgrades. 8 analysts currently cover ORMP.

分析师推荐趋势

Buy ratings1 → 0↓ 1

Hold ratings0 → 1↑ +1

Sell ratings0 → 0

ORMP analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$1M

↓ 66.3% YoY

Revenue Next Year

$1M

↑ 11.3% YoY

EPS This Year

$0.51

EPS Next Year

$-0.24

↓ 146.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ORMP EPS of $0.51 for the current fiscal year, based on estimates from 1 analysts. The ORMP revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ORMP 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ORMP 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

ORMP 的短期预测（明日）为 $3.46（-5.00%）。 ORMP 对 2027 年的股价预测均值为 $3。 ORMP 对 2030 年的预测区间为 $2–$2。

Oramed Pharmaceuticals Inc. 在 NASDAQ 上市，代码 ORMP。ORMP 在 2027 年的整体展望偏积极，在覆盖分析师中约 75% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ORMP 预测 · 8 个问题

根据 8 位华尔街分析师，ORMP 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $3.64，隐含约 +0.0% 的上行空间。

ORMP 目标价ORMP 分析师目标价ORMP 12个月目标价目标价 ORMP

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.